Xi’An Thiebaut Pharmaceutical Packaging Co. Ltd
Xi’an Thiebaut Pharmaceutical Packaging Co., Ltd is a Sino-Belgian joint venture based in the Xi’an National High-tech Zone of China. The company operates as a major player in the design and manufacture of collapsible aluminum tubes, serving industries such as pharmaceuticals, cosmetics, food and fine chemicals. With three shareholders—TS Flanders Belgium, Xi’an Global Printing, and Shaanxi Hanjiang Pharmaceutical Group—the enterprise represents a strategic collaboration between European technology and Chinese manufacturing capabilities. The partnership aligns international experience with local market access, enabling the company to deliver standardized packaging solutions for a range of sensitive products.
Established in May 1999, Xi’an Thiebaut Pharmaceutical Packaging Co., Ltd began with a RMB 125 million investment. This financial foundation supported the development of advanced production facilities and quality assurance systems designed to meet stringent industry requirements. The company’s production lines are described as fully automatic and are reportedly manufactured in Germany, reflecting a commitment to state-of-the-art automation and engineering precision. Such equipment is intended to ensure high-speed output while maintaining consistency and reliability in tube dimensions, wall thickness, and seal integrity—critical factors in the protection and stability of product formulations.
A core focus of the business is the design and manufacture of quality collapsible tubes for a diverse array of end-use applications. The product portfolio is geared toward packaging solutions for pharmaceuticals, which demand rigorous barrier properties and compatibility with active ingredients, as well as for cosmetics, food products, and fine chemicals that may have specific regulatory or market requirements. As a leading supplier in this category, the company emphasizes reliability, hygienic design, and engineering to meet international packaging standards.
The Xi’an facility benefits from its location within a technology-driven industrial park and from access to a skilled workforce trained in high-precision manufacturing. The joint venture structure also provides a bridge to European technology and best practices in tube formation, lamination, and printing, while leveraging local manufacturing strengths and cost efficiencies. While the specific product specifications are not detailed in public materials, typical collapsible aluminum tubes are valued for lightweight performance, compatibility with a wide range of formulations, and recyclability—qualities that align with evolving regulatory and consumer expectations in global markets.
From a market perspective, the company positions itself as both a domestic and international supplier. Its strategic alliance with Belgian and Chinese partners supports cross-border supply chains, enabling customization options for customers who require tailored dimensions, printing options, and functional features such as desiccant-clear caps, liners, or tamper-evident closures. In addition to packaging design, the organization likely engages in core manufacturing services that include extrusion, annealing, lamination or coating of the tube body, as well as the sealing and end-forming processes necessary to ensure product integrity at the point of use.
Quality management and testing infrastructure are implied through the mention of advanced testing equipment accompanying the German-manufactured production lines. Although specific certifications are not enumerated in available materials, the emphasis on automated, high-precision production suggests alignment with international quality standards commonly required in pharmaceutical and consumer product packaging. The company’s long-standing presence since 1999 indicates a track record of reliability and capability to scale with evolving customer demands in a competitive packaging sector.
As a leading supplier of collapsible aluminum tubes, Xi’an Thiebaut Pharmaceutical Packaging Co., Ltd likely emphasizes a holistic approach that encompasses product development support, process optimization, and close collaboration with customers to meet tight regulatory timelines and formulation constraints. The combination of European technology with Chinese manufacturing strength enables the company to offer a combination of performance, efficiency, and cost competitiveness that can be attractive to multinational corporations and regional brands alike.
In a broader context, the packaging industry has continued to evolve toward sustainable materials and efficient supply chains. The company’s aluminum tube solution contributes to lightweight, durable packaging that can reduce transport emissions and support efficient distribution. As consumer expectations around product safety and regulatory compliance rise, the ability to provide robust packaging solutions with clear traceability and consistent performance remains a critical differentiator. Xi’an Thiebaut’s ongoing development within this landscape will likely continue to focus on process optimization, materials innovation, and adherence to the rigorous standards required by pharmaceutical and other regulated sectors.
Overall, Xi’an Thiebaut Pharmaceutical Packaging Co., Ltd stands as a notable example of Sino-European collaboration in high-precision packaging manufacturing. By leveraging European engineering heritage and local manufacturing capabilities, the company aims to deliver dependable collapsible aluminum tubes that meet the demands of pharmaceutical, cosmetic, food, and fine chemical customers while maintaining a focus on quality, efficiency, and market responsiveness.
